Journal of Orthopaedic Surgery and Research, 2023 · DOI: https://doi.org/10.1186/s13018-023-04195-5 · Published: September 13, 2023
This study investigates the role of microglia, key immune cells in the central nervous system, at different times after spinal cord injury (SCI). It uses single-cell RNA sequencing data from mouse spinal cords at 3 and 14 days post-injury to identify inflammatory biomarkers associated with microglia. The research also explores ferroptosis, a form of cell death, and how it relates to inflammation in the CNS after SCI. By examining gene expression in microglia, the study aims to find key genes involved in the immune inflammatory process following SCI. The findings predict key genes, such as Stmn1 and Fgfbr1, involved in the immune inflammatory response associated with microglia at different time points after spinal cord injury at the single-cell level and may provide a molecular basis for better treatment of SCI.
Stmn1 and Tgfbr1, identified as potential biomarkers, could be targeted for therapeutic interventions to modulate microglial inflammatory responses after SCI.
The study identifies potential drug molecules, such as POTASSIUM NITRATE and sertraline for Stmn1, and diazepam for Tgfbr1, that could be further investigated for their therapeutic effects on SCI.
The proposed Stmn1-associated ceRNA regulatory network suggests a potential RNA regulatory mechanism that could be further explored to understand and influence outcomes after SCI.